VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2)

14 June 2016

European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods.

The initiative that started on 1 March 2016 will facilitate the move away from the traditional paradigm of vaccine batch release testing and to accelerate the introduction of a new paradigm based on innovative non-animal techniques, thereby taking into account both vaccine safety and animal welfare.

Full press-release

Participants at kick-off meeting, 22-23 March 2016